Viewing Study NCT00143520


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-07-06 @ 2:02 AM
Study NCT ID: NCT00143520
Status: COMPLETED
Last Update Posted: 2021-05-10
First Post: 2005-09-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes
Sponsor: Daiichi Sankyo
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Placebo and active control dose response study of rivoglitazone in … View